Legal Cannabis Market Set to Expand on Growing CBD Popularity in Medicine

Tuesday, August 21, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, August 21, 2018 /PRNewswire/ --

According to a research

report provided by Technavio, the legal cannabis market is expected to grow at a steady CAGR of about 24% until 2021. The widespread proliferation of cannabidiol (CBD) oil products is one of the primary growth factors for the market. The growing presence
of online retailers is also projected to significantly impact sales rates of the legal cannabis market. Overall, the medical applications of CBD, as well as the growing awareness of them, is what helps this segment of the industry witness a drastic increase in popularity in recent years. Technavio's Research analysis on the global CBD oil market indicates that CBD oil is highly recommended because it can suppress the growth of cancer cells and helps in the fight to prevent cancer. Focusing on the CBD segment, the research predicts that it will grow at a CAGR of more than 39% by 2021. SinglePoint Inc. (OTC: SING), Isodiol International Inc. (OTC: ISOLF), PotNetwork Holdings Inc. (OTC: POTN), Future Farm Technologies Inc. (OTC: FFRMF), MassRoots Inc. (OTC: MSRT)

So far, this year has been crucial for the cannabis industry. Canada has legalized cannabis on a national level, and the state of California has legalized sales of cannabis products for recreational use. These recent developments are expected to have significant financial and economic implications. A report by Fortune indicates that, "In order to collect USD 1 Billion a year in taxes, the state will need to reach a projected USD 7 Billion in annual legal recreational cannabis sales. At that rate, California would easily be the country's largest legal marijuana market, as the entire legal cannabis industry in the U.S. is expected to pull in roughly USD 10 Billion in total sales for 2017. That number would almost certainly get a boost in the coming years, as legal markets grow in California and other states, such as Nevada and Massachusetts."

SinglePoint Inc. (OTC: SING) earlier today announced breaking news that, "its status as a fully reporting company by way of filing Form 10-12G and reports year-over-year improvements for the second quarter and six months ended June 30, 2018.

Second-quarter revenues increased nearly 100% compared to the same quarter of 2017. In the first six months of 2018, SinglePoint recorded over $500,000 in revenue as a result of several successful acquisitions. The company hopes to maintain this growth trend through its current business model.

Acquisitions have been a key factor in building a solid financial base, and SinglePoint intends to continue accelerating revenue growth through strategic acquisitions. Under this model, the company expects to grow organically and through larger investments and/or acquisitions.

"As a fully reporting company, I believe we will have additional opportunities to grow our existing businesses and potentially entertain larger acquisitions," stated CEO Greg Lambrecht. "We are excited to continue business with increased transparency and credibility. It took all of our efforts and attention to file the Form 10-12G, and we are now ready and able to fully focus on the deals in front of us."

To see the full filing, visit

About SinglePoint, Inc. - SinglePoint, Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from our management, potential injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base." Isodiol International Inc. (OTCQB: ISOLF) is the market leader in pharmaceutical-grade pure, natural CBD and in the manufacturing and development of CBD consumer products. Recently, the Company announced the progress of its months-long efforts to develop new hemp-based beers and functional beverages. In May 2018, IsoBev Inc., a wholly owned subsidiary of Isodiol, acquired a turn-key brewing system, including a 7-bbl brewhouse, four 15-bbl fermentation tanks, a 30-bbl fermentation tank, a 15-bbl brite tank, and a 30-bbl brite tank, which is expected to yield between 1,500 and 2,000 bbls of production per year. In addition, IsoBev acquired a 12-ounce bottling line and a 22-ounce bottling line, which could yield over 600,000 12-oz bottles and 25,000 12-oz bottle cases per year.  PotNetwork Holdings Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD Inc., the maker of Diamond CBD oils. Earlier this month, the Company announced that its wholly owned subsidiary, Diamond CBD Inc., successfully displayed the Company's full product line including its newest products at the 56th ASD Market Week trade show at the Las Vegas Convention Center, July 29-August 1st, gaining over 400 new orders in the 3 days of the show. With products in all 50 states, and a growing international brand awareness, Diamond CBD is a growing industry leader with proprietary premium products that contain a broad range of cannabinoids, natural hemp derivatives and hemp extracts.

Future Farm Technologies Inc. (OTCQX: FFRMF) is a Canadian company with holdings throughout North America including California, Massachusetts, Florida, Maine, Puerto Rico and Newfoundland. Recently, the Company announced that it has completed its acquisition of a 50% interest in CEPG Consulting and Design Inc. of St. John's, Newfoundland. CEPG will participate in the cannabis and hemp breeding program under the previously announced joint venture between Future Farm and Rahan Meristem Ltd., a world-renowned global agro-biotechnology company based in Israel. The joint venture will operate out of both an existing building to be transferred to CEPG by Snellen Holdings (1994) Co. Ltd. and 6,000 sq. ft. of newly constructed laboratories. CEPG will apply for a dealer license from Health Canada, which will enable research and development to begin on the growth of cannabis plants. Once licensed, the R&D facility will use state-of-the-art controlled environment equipment and techniques to create a research hub for the Rahan and Future Farm JV, which is expected to create valuable IP to be sold or licensed worldwide.

MassRoots Inc. (OTCQB: MSRT) is one of the leading technology platforms for the regulated cannabis industry. Powered by more than one million registered users, the Company's mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews. With a significant market share of medical cannabis patients in certain markets and more than 35,000 shareholders, the Company believes it is uniquely positioned to best serve the needs of the cannabis industry. Recently, the Company announced that it has launched its revamped dispensary portal, MassRoots for Business. Through this business portal, dispensaries are able to list locations on MassRoots' dispensary finder, update key information in real-time, and view insightful analytics on their local cannabis market.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For SinglePoint Inc. financial news dissemination and PR services, expects to be compensated five thousand dollars for financial news dissemination and PR services by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .

Media Contact: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store